Literature DB >> 10867442

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

G P Eckert1, N J Cairns, A Maras, W F Gattaz, W E Müller.   

Abstract

Cholesterol represents an important determinant of the physical state of biological membranes. In Alzheimer's disease (AD) brains, specific changes in the distribution of cholesterol and its membrane-ordering effects take place. In the present study, membrane fluidity was investigated at the level of the hydrocarbon core and of the heads of the phospholipid bilayers using two different fluorescent probes. Hippocampal membranes of AD brains showed a reduced fluidity in the hydrocarbon core region only. Fluidity was correlated with the cholesterol content in AD and control membranes. Aggregated beta-amyloid peptides (Abeta) disrupted brain membrane structure in AD patients and controls in the same fashion. However, this effect was correlated with the cholesterol content in AD membranes only. It is suggested that in AD the brain becomes specifically sensitive for the modulation by membrane-bound cholesterol of the membrane-disturbing and ultimately neurotoxic properties of Abeta. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867442     DOI: 10.1159/000017234

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  40 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

2.  Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

Authors:  Stefan Smesny; Susan Stein; Ingo Willhardt; Jürgen Lasch; Heinrich Sauer
Journal:  J Neural Transm (Vienna)       Date:  2008-06-27       Impact factor: 3.575

3.  Sex-dependent actions of amyloid beta peptides on hippocampal choline carriers of postnatal rats.

Authors:  Z Kristofiková; J Rícný; I Kozmiková; D Rípová; P Zach; J Klaschka
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

4.  Age- and sex-dependent effects of ethanol on hippocampal hemicholinium-3 sensitive choline carriers during postnatal development of rats.

Authors:  Zdena Kristofiková; Veronika Platilová; Jan Klaschka
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 5.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 6.  Alzheimer disease--no target for statin treatment. A mini review.

Authors:  Siegfried Hoyer; Peter Riederer
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

Review 7.  Alzheimer's disease and cholesterol: the fat connection.

Authors:  Laura Canevari; John B Clark
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

8.  Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 9.  Alois Alzheimer revisited: differences in origin of the disease carrying his name.

Authors:  K Maurer; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

Review 10.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.